Characterization and inhibition of a p38-like mitogen-activated protein kinase (MAPK) from Echinococcus multilocularis: antiparasitic activities of p38 MAPK inhibitors

scientific article published on 22 August 2008

Characterization and inhibition of a p38-like mitogen-activated protein kinase (MAPK) from Echinococcus multilocularis: antiparasitic activities of p38 MAPK inhibitors is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BCP.2008.08.020
P698PubMed publication ID18789902

P2093author name stringKlaus Brehm
Verena Gelmedin
Rocio Caballero-Gamiz
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectEchinococcus multilocularisQ669922
P304page(s)1068-1081
P577publication date2008-08-22
P1433published inBiochemical PharmacologyQ864229
P1476titleCharacterization and inhibition of a p38-like mitogen-activated protein kinase (MAPK) from Echinococcus multilocularis: antiparasitic activities of p38 MAPK inhibitors
P478volume76

Reverse relations

cites work (P2860)
Q28608107A Novel Terminal-Repeat Retrotransposon in Miniature (TRIM) Is Massively Expressed in Echinococcus multilocularis Stem Cells
Q33972939Cestode genomics - progress and prospects for advancing basic and applied aspects of flatworm biology
Q38093067Current drug targets for helminthic diseases
Q30491719Development of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds.
Q36291446EGF-mediated EGFR/ERK signaling pathway promotes germinative cell proliferation in Echinococcus multilocularis that contributes to larval growth and development
Q37771996Echinococcosis with particular reference to Southeast Asia
Q37599990Echinococcus metacestodes as laboratory models for the screening of drugs against cestodes and trematodes.
Q37719252Echinococcus multilocularis and its intermediate host: a model of parasite-host interplay
Q51921125Echinococcus multilocularis as an experimental model in stem cell research and molecular host-parasite interaction.
Q38697065Enzyme Activity Assays for Protein Kinases: Strategies to Identify Active Substrates
Q41952623Host insulin stimulates Echinococcus multilocularis insulin signalling pathways and larval development.
Q38974051Identification and characterization of functional Smad8 and Smad4 homologues from Echinococcus granulosus
Q57800910Identification of functional MKK3/6 and MEK1/2homologs from and investigation of protoscolecidal activity of MAPK signaling pathway inhibitors and
Q42630662Identification of putative insulin-like peptides and components of insulin signaling pathways in parasitic platyhelminths by the use of genome-wide screening.
Q34529138In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.
Q48007887In vitro and in vivo efficacies of novel carbazole aminoalcohols in the treatment of cystic echinococcosis
Q36869148In vitro effects of SB202190 on Echinococcus granulosus
Q38627137In vitro efficacy of dicationic compounds and mefloquine enantiomers against Echinococcus multilocularis metacestodes
Q42272747In vitro efficacy of triclabendazole and clorsulon against the larval stage of Echinococcus multilocularis
Q52723676Modulation of human melanoma cell proliferation and apoptosis by hydatid cyst fluid of Echinococcus granulosus.
Q37606590Molecular Cloning and Characterization of a P38-Like Mitogen-Activated Protein Kinase from Echinococcus granulosus.
Q51888514Molecular characterisation of a serum-responsive, DAF-12-like nuclear hormone receptor of the fox-tapeworm Echinococcus multilocularis.
Q42260166Molecular characterization of EmABP, an apolipoprotein A-I binding protein secreted by the Echinococcus multilocularis metacestode
Q38294864On the importance of targeting parasite stem cells in anti-echinococcosis drug development.
Q52574425Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets.
Q26795698Recent advances in Echinococcus genomics and stem cell research
Q34584194TGF-β and TGF-β/Smad signaling in the interactions between Echinococcus multilocularis and its hosts
Q28539389Targeting Echinococcus multilocularis stem cells by inhibition of the Polo-like kinase EmPlk1
Q89869922The importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosis
Q37727046The role of evolutionarily conserved signalling systems in Echinococcus multilocularis development and host-parasite interaction
Q34741945Treatment of echinococcosis: albendazole and mebendazole--what else?
Q27336465Using existing drugs as leads for broad spectrum anthelmintics targeting protein kinases

Search more.